The Impacts of the Covid-19 Pandemic on the Medical Expenditure Panel Survey
Bibliographic Data
| ID | 11025876 |
|---|---|
| Authors | Samuel H Zuvekas (Samuel H. Zuvekas and David Kashihara are with the Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD.), David Kashihara (Samuel H. Zuvekas and David Kashihara are with the Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD.) |
| Year | 2021 |
| Volume | 111 |
| Issue | 12 |
| Pages | 2157-2166 |
| Publication date | 2021-12-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | American Journal of Public Health (JOURNAL) |
| Journal identifiers | ISSN: 0090-0036 • E-ISSN: 1541-0048 |
| Publisher | American Public Health Association (PUBLISHER • US) |
| DOI | 10.2105/ajph.2021.306534 |
| PMID | 34878880 |
| OpenAlex | W4200409566 |
| Language | EN |
| Citations received | 2 |
| References cited | 11 |
The COVID-19 pandemic caused substantial disruptions in the field operations of all 3 major components of the Medical Expenditure Panel Survey (MEPS). The MEPS is widely used to study how policy changes and major shocks, such as the COVID-19 pandemic, affect insurance coverage, access, and preventive and other health care utilization and how these relate to population health. We describe how the MEPS program successfully responded to these challenges by reengineering field operations, including survey modes, to complete data collection and maintain data release schedules. The impact of the pandemic on response rates varied considerably across the MEPS. Investigations to date show little effect on the quality of data collected. However, lower response rates may reduce the statistical precision of some estimates. We also describe several enhancements made to the MEPS that will allow researchers to better understand the impact of the pandemic on US residents, employers, and the US health care system. (Am J Public Health. 2021;111(12):2157–2166. https://doi.org/10.2105/AJPH.2021.306534 )
Coronavirus disease 2019 (COVID-19) · Data collection · Disease · Economic growth · Economics · Environmental health · Health care · Health insurance · Medical Expenditure Panel Survey · Pandemic · Population · Public health · Statistics · Survey data collection · COVID-19 and healthcare impacts · Health disparities and outcomes · Healthcare Policy and Management · Medicine · Nursing
Implications of the Accuracy of Meps Prescription Drug Data for Health Services Research
The Capacity of the Medical Expenditure Panel Survey to Inform the Affordable Care Act
Intersection of Living in a Rural Versus Urban Area and Race/Ethnicity in Explaining Access to Health Care in the United States
The Myth Regarding the High Cost of End-of-Life Care
Racial and Ethnic Disparities in Services and the Patient Protection and Affordable Care Act
The Relationship Between Living Arrangement and Preventive Care Use Among Community-Dwelling Elderly Persons
Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996–2013
The Medical Expenditure Panel Survey
| Unique citing works | 2 |
|---|---|
| Citations per year | 2 |
| Citation span | 2025 - 2025 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 2 |